1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. United States >
  5. Pennsylvania >
  6. Paratek Pharmaceuticals Acquires OptiNose

M&A Deal Summary

Paratek Pharmaceuticals Acquires OptiNose

On March 19, 2025, Paratek Pharmaceuticals acquired medical products company OptiNose for 330M USD

Acquisition Highlights
  • This is Paratek Pharmaceuticals’ 2nd transaction in the Medical Products sector.
  • This is Paratek Pharmaceuticals’ largest (disclosed) transaction.
  • This is Paratek Pharmaceuticals’ 2nd transaction in the United States.
  • This is Paratek Pharmaceuticals’ 1st transaction in Pennsylvania.

M&A Deal Summary
Date 2025-03-19
Target OptiNose
Sector Medical Products
Buyer(s) Paratek Pharmaceuticals
Deal Type Add-on Acquisition
Deal Value 330M USD
Advisor(s) Evercore Group (Financial)
Hogan Lovells (Legal)

Target

OptiNose

Yardley, Pennsylvania, United States
OptiNose is a specialty pharmaceutical company focused on the development and commercialization of products for patients cared for by, or in consultation with, ear, nose, and throat (ENT) or allergy specialists. OptiNose was founded in 2000 and is based in Yardley, Pennsylvania.

Search 205,401 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Paratek Pharmaceuticals

King of Prussia, Pennsylvania, United States
Category Company
Founded 1996
Sector Life Science
Employees101
Revenue 47M USD (2020)
DESCRIPTION

Paratek Pharmaceuticals is a bio-pharmaceutical company focused on the development and commercialization of innovative therapies based upon its expertise in novel tetracycline chemistry. Paratek Pharmaceuticals was founded in 1996 and is based in King of Prussia, Pennsylvania.

DEAL STATS #
Overall 2 of 2
Sector (Medical Products) 2 of 2
Type (Add-on Acquisition) 2 of 2
State (Pennsylvania) 1 of 1
Country (United States) 2 of 2
Year (2025) 1 of 1
Size (of disclosed) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2014-10-30 Transcept Pharmaceuticals

Pt. Richmond, California, United States

Transcept Pharmaceuticals, Inc. is a pharmaceutical company focuses on the development and commercialization of proprietary products that address important therapeutic needs in the field of neuroscience.

Buy -
Mergr

Product

Company

Legal